Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. EMEA/
      2. Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant

      Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant

      January 3, 2022
      1 min read

      Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant